A team of scientists has come up with artificial, long-lasting, easily portable platelets that could revolutionise trauma care.
Median overall survival, a secondary endpoint, reached nearly 3.5 years with Johnson & Johnson's RYBREVANT® plus LAZCLUZE® in atypical EGFR-mutated disease Consistent ...
The Daily Galaxy on MSN
Scientists on the ISS investigate a hidden health threat that could affect future moon missions
Aboard the International Space Station, astronauts are tackling one of the most important medical questions facing future ...
It's tricky to make an exact copy of yourself. Or at least it is for cells undergoing mitosis, where cells replicate ...
DECNUPAZ is the first and only antibody-drug conjugate (ADC) approved for blastic plasmacytoid dendritic cell neoplasm (BPDCN) that is initiated in an outpatient ...
A multicentre clinical trial led by Washington University School of Medicine in St Louis has shown that donor stem cells ...
Almost all animal species -- including humans -- have blood cells, but between different species our blood tells different ...
Morning Overview on MSN
A topical drug called ABT-263 just healed aging skin faster by clearing out the worn-out 'zombie' cells that stall the body's repair crew
A cut that would close in days on a 25-year-old can linger for weeks on a 75-year-old, and the usual explanations (thinner ...
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful ...
RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 10:30 AM EDTCompany ParticipantsSteven Stein - Executive ...
Quiz: Which blood tests matter most for aging adults? Most people know they should get blood work done. Fewer know what each ...
Scientists say the powdered synthetic platelets could help save trauma patients in ambulances, on battlefields and in remote areas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results